Equities

Clearpoint Neuro Inc

CLPT:NAQ

Clearpoint Neuro Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)11.12
  • Today's Change0.16 / 1.46%
  • Shares traded94.56k
  • 1 Year change+87.21%
  • Beta1.0840
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

  • Revenue in USD (TTM)30.43m
  • Net income in USD-18.15m
  • Incorporated1998
  • Employees107.00
  • Location
    Clearpoint Neuro Inc120 S. SIERRA AVENUE, SUITE 100SOLANA BEACH 92075United StatesUSA
  • Phone+1 (949) 900-6833
  • Fax+1 (949) 900-6834
  • Websitehttps://www.clearpointneuro.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
LifeMD Inc193.06m-25.61m233.43m207.00------1.21-0.6409-0.64094.85-0.18473.416.2136.89932,652.80-39.18-153.05-240.82-526.9189.6483.66-11.49-45.440.7805-8.831.49--28.1578.9051.27--143.64--
Pulmonx Corp79.30m-57.11m244.82m279.00--2.61--3.09-1.47-1.472.042.380.451.247.29284,236.60-32.41-26.27-36.42-28.9774.1671.95-72.01-93.766.77--0.2839--27.9827.98-3.26--20.62--
Electromed Inc57.06m6.47m245.51m174.0040.265.9533.564.300.72560.72566.404.911.233.372.42327,931.0013.918.6416.2210.0976.6276.2611.348.065.06--0.000.0013.8311.8262.6721.06-22.23--
Trubridge Inc337.67m-58.25m246.56m3.22k--1.43--0.7302-4.09-4.0923.6711.570.8126183.565.84104,900.30-14.401.25-16.501.4149.3150.40-17.721.561.780.80550.505245.063.913.89-387.73--88.71--
Zynex Inc193.67m4.82m250.31m1.10k53.087.1126.771.290.14810.14815.911.111.402.577.05176,059.103.4814.584.0617.5280.2079.622.4910.443.154.150.6246--16.5442.01-42.910.37412.19--
Anika Therapeutics Inc164.17m-97.52m251.61m357.00--1.40--1.53-6.64-6.6411.1412.240.58681.475.21459,854.30-34.86-5.41-38.55-5.8762.7060.70-59.40-12.603.78--0.00--6.679.56-456.34--3.11--
Atlantic International Corp313.06m-68.07m260.76m7.00--14.53--0.8329-5.55-5.5512.450.3584.44--10.4844,723,330.00-96.45-71.97-233.48-106.0910.8161.01-21.74-1,471.82---1.640.8328---100.00---37.43------
AngioDynamics, Inc.292.73m-243.03m273.87m748.00--1.41--0.9356-6.04-6.047.254.790.74342.276.55391,344.90-61.72-16.38-74.39-18.7051.7152.95-83.02-30.491.41--0.00---10.282.35-251.53--13.09--
Neuropace Inc76.45m-28.09m274.30m171.00--27.86--3.59-0.9924-0.99242.700.32990.78171.836.69447,087.70-28.72---33.44--73.83---36.74--4.77-4.060.8578--43.72--30.00------
OraSure Technologies, Inc.224.26m11.37m284.20m638.0025.300.667811.611.270.15060.15063.015.710.48622.645.58351,509.402.720.72382.940.821242.2646.945.591.1311.20--0.00040.004.6417.41413.1782.2010.18--
Clearpoint Neuro Inc30.43m-18.15m302.33m107.00--10.43--9.94-0.6912-0.69121.161.050.72421.509.66284,383.20-43.19-34.75-51.20-39.6760.3864.75-59.64-76.913.61--0.00--16.5626.64-34.40--75.30--
Delcath Systems Inc22.64m-34.12m307.91m76.00--31.48--13.60-1.36-1.360.83430.30590.57140.90946.34297,947.40-86.11-116.57-156.17-243.2181.3171.02-150.70-1,235.371.03-172.600.1892---24.05-9.53-30.60---5.26--
Cerus Corp197.91m-19.73m308.29m288.00--5.76--1.56-0.1076-0.10761.080.28821.001.977.88687,194.40-10.01-25.99-15.26-40.6260.5261.90-10.00-35.811.92-1.190.6057---0.806119.6912.37--32.07--
CVRx Inc47.26m-58.48m328.04m200.00--5.02--6.94-2.71-2.712.192.690.40380.6576.14236,275.00-49.96---54.21--84.16---123.75--10.23-17.040.4302--74.89--0.5528------
Nano-X Imaging Ltd10.13m-57.47m344.55m164.00--1.97--34.02-0.9974-0.99740.17552.990.0482--6.8961,756.10-27.33-30.98-29.96-35.10-81.80---567.41-1,527.245.09--0.0181--15.47--46.33--114.35--
MaxCyte Inc45.60m-35.74m368.13m143.00--1.72--8.07-0.3420-0.34200.43682.030.1770.55767.17318,878.30-13.87-13.18-14.86-14.3385.9888.79-78.37-62.969.22--0.00---6.7219.89-60.89--39.13--
Data as of Nov 21 2024. Currency figures normalised to Clearpoint Neuro Inc's reporting currency: US Dollar USD

Institutional shareholders

15.06%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 20241.23m4.47%
Essex Investment Management Co. LLCas of 30 Sep 2024463.85k1.68%
Taylor Frigon Capital Management LLCas of 30 Sep 2024374.80k1.36%
BlackRock Fund Advisorsas of 30 Sep 2024366.44k1.33%
Brown Advisory LLCas of 30 Sep 2024333.40k1.21%
CM Management LLCas of 30 Sep 2024300.00k1.09%
Geode Capital Management LLCas of 30 Sep 2024287.29k1.04%
Marshall Wace LLPas of 30 Sep 2024276.63k1.00%
Millennium Management LLCas of 30 Sep 2024275.28k1.00%
Cahill Wealth Management LLCas of 30 Sep 2024244.42k0.89%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.